1.
Indian Heart J
; 39(1): 15-7, 1987.
Article
in English
| MEDLINE
| ID: mdl-3330048
2.
J Assoc Physicians India
; 34(10): 716-7, 1986 Oct.
Article
in English
| MEDLINE
| ID: mdl-3818521
3.
Indian Heart J
; 34(4): 260-1, 1982.
Article
in English
| MEDLINE
| ID: mdl-7141457
4.
Chemotherapy
; 28(4): 298-303, 1982.
Article
in English
| MEDLINE
| ID: mdl-6749447
ABSTRACT
In this double-blind, placebo-controlled study, treatment of 60 acute hepatitis patients with ribavirin resulted in a more rapid reduction of abnormal laboratory values when compared with the placebo group. Moreover, improved clinical status as reflected by increased appetite with resultant weight gain was noted to be significantly greater in the ribavirin-treated patients. Ribavirin was well tolerated. With this dosage regimen, there were no side effects or changes in laboratory values that could be associated with drug-related toxicity. Since hepatitis A is one of the most common viral infections afflicting the Indian population, the use of a safe and effective therapeutic agent, such as ribavirin, will be necessary to treat these cases.
Subject(s)
Hepatitis A/drug therapy , Ribavirin/therapeutic use , Ribonucleosides/therapeutic use , Adolescent , Adult , Alanine Transaminase/blood , Aspartate Aminotransferases/blood , Bilirubin/blood , Body Weight , Child , Clinical Trials as Topic , Double-Blind Method , Female , Hepatitis A/blood , Humans , Male , Middle Aged
5.
J Assoc Physicians India
; 27(2): 143-7, 1979 Feb.
Article
in English
| MEDLINE
| ID: mdl-511829
6.
Neurol India
; 25(3): 184-8, 1977 Sep.
Article
in English
| MEDLINE
| ID: mdl-613264